1. Alamanda VK, Crosby SN, Archer KR et al.: Amputation for extremity soft tissue sarcoma does not increase overall survival: a retrospective cohort study. Eur J Surg Oncol 38(12) (2012) 1178–1183. doi:10.1016/j.ejso.2012.08.024.
2. Amin MB, Edge SB, Greene F et al.: AJCC Cancer Staging Manual, 8th ed. Springer International Publishing, New York (2017).
3. AWMF: Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Adulte Weichgewebesarkome, Langversion 1.1, 2022, AWMF-Registernummer: 032/044OL. www.leitlinienprogramm-onkologie.de/leitlinien/adulte-weichgewebesarkome/ (letzter Zugriff: 25.6.2023).
4. Billing V, Mertens F, Domanski HA, Rydholmet A.: Deep-seated ordinary and atypical lipomas: histopathology, cytogenetics, clinical features, and outcome in 215 tumours of the extremity and trunk wall. J Bone Joint Surg Br 90(7) (2008) 929–933.
5. Bitz U, Pink D, Busemann C, Reichardt P: Doxorubicin and dacarbazine as first-line therapy for patients with locally advaned or metastatic leiomyosarcoma and liposarcoma. JCO 29 (2011) (suppl; abstr 10094).